SecBot SecBot
Insider Cluster (9 insiders) ·Filed Mar 31, 2026

PCSA

Processa Pharmaceuticals, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed5mo ago
Insider cluster: 9 insiders, $0.0M total
Actionable Insight ▲ Bullish

Unanimous insider buying at a micro-cap biotech with 86% analyst bullishness suggests management sees material upside. Monitor for near-term catalysts (trial data, partnership, financing). The cluster's size relative to market cap is unusually large for a single week — treat as a strong vote of confidence.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
PCSA ▼ -26.34% at T+60d
LONG call ✗ call lost -26.34% · α vs SPY -38.72% · entry $2.53 → $1.86
Entry = T+0 close
Mar 30, 2026
via day close
T+1d
+3.09%
call +3.09% · α +2.34%
$2.60
settled 7mo ago
T+5d
+19.60%
call +19.60% · α +15.66%
$3.02
settled 7mo ago
T+20d
+4.95%
call +4.95% · α -4.47%
$2.65
settled 6mo ago
T+60d
-26.34%
call -26.34% · α -38.72%
$1.86
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Nine insiders at Processa Pharmaceuticals, including the CEO, CFO, and multiple directors, made open-market purchases totaling $43K at $2.54/share over a 7-day window. This represents approximately 0.6% of the company's $7M market cap — a significant cluster by proportionality. The buying is unanimous and concentrated among top leadership, signaling strong conviction ahead of a potential catalyst.

Key Financial Metrics

Direction
buying
Total Value
$43.0K
Insiders
9

Key Facts

  • 9 insiders bought $43K in open-market purchases at $2.54/share
  • CEO George Ng bought $5K, CFO Russell Skibsted bought $6K
  • Total cluster value is ~0.6% of $7M market cap
  • All 9 trades were open-market buys (code P) — no sales or non-cash transactions
  • Prior 30-day insider activity: 7 buys totaling $36K, now accelerating

Financial Impact

$43K in insider purchases, ~0.6% of market cap

insider ownershipmarket sentiment

Risk Factors

  • Micro-cap biotech with $7M market cap is inherently high-risk and illiquid
  • Insider buying does not guarantee positive catalysts — clinical failures can destroy value

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PCSA-1777581232417
14 reports for PCSA
Performance horizon
60% Hit rate @ T+5 6 of 10 directional calls Went positive at some point 8 of 10 best @ T+5▲ +19.60%Mar 31, 2026
Filters
Rows
Reports for PCSA — sortable, filterable
TypeNow
Oct 26, 2026
1d ago
EFFECT
BEARISH ★ 6/10
$1.81awaiting T+5—$1.83 (−1.10%)
Oct 22, 2026
4d ago
DEF 14A
NEUTRAL ★ 4/10
$1.81awaiting T+5—$1.83 (+1.10%)
Oct 9, 2026
17d ago
S-3
BEARISH ★ 7/10
$1.90 $1.73▲ +8.95%▲ +7.45%$1.83 (+3.68%)
Jul 29, 2026
12w ago
8-K
MIXED ★ 6/10
$2.03 $2.19▲ +7.88%▲ +2.35%$1.83 (−9.85%)
Jul 1, 2026
16w ago
Insider Cluster
BULLISH ★ 5/10
$2.16 $2.16· 0.00%▼ −1.37%$1.83 (−15.28%)
Jun 16, 2026
18w ago
Insider Cluster
BULLISH ★ 5/10
$2.15 $1.93▼ −10.23%▼ −9.19%$1.83 (−14.88%)
Jun 16, 2026
18w ago
Insider Cluster
BULLISH ★ 4/10
$2.15 $1.93▼ −10.23%▼ −9.19%$1.83 (−14.88%)
Jun 1, 2026
21w ago
Insider Cluster
BULLISH ★ 4/10
$2.92 $2.04▼ −30.31%▼ −27.34%$1.83 (−37.33%)
May 19, 2026
22w ago
Insider Cluster
BULLISH ★ 5/10
$2.61 $2.64▲ +1.15%▼ −0.65%$1.83 (−29.89%)
May 19, 2026
22w ago
Insider Cluster
BULLISH ★ 5/10
$2.61 $2.64▲ +1.15%▼ −0.65%$1.83 (−29.89%)
Showing 10 of 14

US Market Status

Market Open — Closes in 4h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 30, 2026